Impact of cognitive function on oral perception in independently living older people

2018 ◽  
Vol 23 (1) ◽  
pp. 267-271
Author(s):  
Motoyoshi Fukutake ◽  
Taiji Ogawa ◽  
Kazunori Ikebe ◽  
Yusuke Mihara ◽  
Chisato Inomata ◽  
...  
Author(s):  
Jumpei Mizuno ◽  
Daisuke Saito ◽  
Ken Sadohara ◽  
Misato Nihei ◽  
Shinichi Ohnaka ◽  
...  

Information support robots (ISRs) have the potential to assist older people living alone to have an independent life. However, the effects of ISRs on the daily activity, especially the sleep patterns, of older people have not been clarified; moreover, it is unclear whether the effects of ISRs depend on the levels of cognitive function. To investigate these effects, we introduced an ISR into the actual living environment and then quantified induced changes according to the levels of cognitive function. Older people who maintained their cognitive function demonstrated the following behavioral changes after using the ISR: faster wake-up times, reduced sleep duration, and increased amount of activity in the daytime (p < 0.05, r = 0.77; p < 0.05, r = 0.89, and p < 0.1, r = 0.70, respectively). The results suggest that the ISR is beneficial in supporting the independence of older people living alone since living alone is associated with disturbed sleep patterns and low physical activity. The impact of the ISR on daily activity was more remarkable in the subjects with high cognitive function than in those with low cognitive function. These findings suggest that cognitive function is useful information in the ISR adaptation process. The present study has more solid external validity than that of a controlled environment study since it was done in a personal residential space.


2019 ◽  
Author(s):  
Carlota Grossi ◽  
Kathryn Richardson ◽  
George Savva ◽  
Chris Fox ◽  
Antony Arthur ◽  
...  

Abstract Background: Anticholinergic medication use is linked with increased cognitive decline, dementia, falls and mortality. The characteristics of the population who use anticholinergic medication are not known. Here we estimate the prevalence of anticholinergic use in England’s older population in 1991 and 2011, and describe changes in use by participant’s age, sex, cognition and disability. Methods: We compared data from participants aged 65+ years from the Cognitive Function and Ageing Studies (CFAS I and II), collected during 1990-1993 (N=7,635) and 2008-2011 (N=7,762). We estimated the prevalence of potent anticholinergic use (Anticholinergic Cognitive Burden [ACB] score=3) and average anticholinergic burden (sum of ACB scores), using inverse probability weights standardised to the 2011 UK population. These were stratified by age, sex, Mini-Mental State Examination score, and activities of daily living (ADL) or instrumental ADL (IADL) disability. Results: Prevalence of potent anticholinergic use increased from 5.7% (95% Confidence Interval [CI] 5.2-6.3%) of the older population in 1990-93 to 9.9% (9.3-10.7%) in 2008-11, adjusted odds ratio of 1.90 (95%CI 1.67 – 2.16). People with clinically significant cognitive impairment (MMSE [Mini Mental State Examination] 21 or less) were the heaviest users of potent anticholinergic in CFAS II (16.5% [95%CI 12.0-22.3%]). Large increases in the prevalence of the use medication with ‘any’ anticholinergic activity were seen in older people with clinically significant cognitive impairment (53.3% in CFAS I to 71.5% in CFAS II). Conclusions: Use of potent anticholinergic medications nearly doubled in England’s older population over 20 years with some of the greatest increases amongst those particularly vulnerable to anticholinergic side-effects. Key words: cognitive impairment, anticholinergic burden, polypharmacy


1995 ◽  
Vol 10 (1) ◽  
pp. 48-53 ◽  
Author(s):  
Dorit Carmelli ◽  
Gary E. Swan ◽  
Lon R. Cardon

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Carlota M. Grossi ◽  
Kathryn Richardson ◽  
George M. Savva ◽  
Chris Fox ◽  
Antony Arthur ◽  
...  

2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S263-S264
Author(s):  
Cherrie Galletly ◽  
Shuichi Suetani ◽  
Duncan McKellar ◽  
David J Castle

Abstract Background Whilst there is considerable focus on early intervention for young people with psychotic disorders, there is little research looking at older people. Although some of these individuals have a recent onset, most will have been living with psychosis for many years. The older population has increased risks of cardiometabolic complications and this is likely to be complicated by psychosis. Methods The Australian Survey of People Living with Psychosis included 1478 participants aged 18–49 years, and 346 participants aged 50–64 years. The two groups were compared across a range of demographic, diagnostic, physical health, substance abuse and lifestyle factors. Results The older group contained significantly more women (48.3% vs 38.6%, p&lt;0.0001). There was a smaller proportion of people with ICD-10 schizophrenia (36.1% vs 45.4% p&lt;0.012), and higher proportions with schizoaffective disorder and affective psychoses. Significantly fewer of the older participants were prescribed clozapine (11.0% vs 16.8%, p &lt; 0.0001). The mean age of onset was later in the older group (30.05 vs 22.23 years, p &lt; 0.0001). There was a striking difference in rates of drug and alcohol abuse. The older group had lower rates of hazardous, harmful or dependent drinking (15.3% vs 35.9%, p &lt; 0.0001), lifetime cannabis use (35.6% vs 74.1%, p &lt; 0.0001), past year cannabis use (11.1% vs 38.1%, p &lt; 0.0001), lifetime amphetamine use (12.8% vs 47.0%, p &lt; 0.0001), and past year amphetamine use (2.9% vs 14.9%, p &lt; 0.0001). The older group were also less likely to currently smoke tobacco (56.9% vs 68.9%, p &lt; 0.0001). Older people were more likely to live alone (45.1% vs 28.6%, p &lt; 0.000). They were less likely to experience food poverty; in the last year 19.5% of older people and 30.7% of younger people had run out of food and did not have money to buy more. Cognitive function was poorer with slower processing speed in the older group, with the NART error score indicating premorbid intelligence was lower in the older group. Older people were more likely to be overweight or obese (80.6% vs 74.3%, p &lt; 0.0001), as well as being more likely to have metabolic syndrome (56.1% vs 48.5%, p = 0.034). There was a greater proportion with very low exercise in the older group (41.6% vs 31.7% p = 0.003). Discussion Older people with psychosis are more likely to be female and more likely to be diagnosed with an affective psychosis. The poorer cognitive function and higher rates of obesity and metabolic syndrome are consistent with changes seen in aging in the normal population. The older group have much lower rates of both lifetime and current drug and alcohol abuse, and smoking. Whilst there is considerable attention to cardiovascular health as a determinant of premature mortality, our results suggest that lifetime alcohol, cannabis and amphetamine use may also be associated with failure to survive into older age.


Sign in / Sign up

Export Citation Format

Share Document